6R-BH4 News
Most Popular 6R-BH4 Story
BioMarin reveals positive Phase II results
California's BioMarin Pharmaceutical announced positive results from a trial of the oral drug 6R-BH4 in patients with sickle cell disease. In the trial, 6R-BH4 was associated with improvement in Read more...
Latest Headlines
- October 16, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
